Apollomics (APLM) Treasury Shares (2021 - 2023)
Apollomics' (APLM) quarterly Treasury Shares came in at $68000.0 in Q4 2023, up 200.0% year-over-year from $22666.7 in Q4 2022, and up 200.0% quarter-over-quarter from -$68000.0 in Q4 2022.
Analysis
Apollomics (APLM) Treasury Shares (2021 - 2023) Analysis & Trends
Apollomics (APLM) has reported Treasury Shares for 3 consecutive years, with $68000.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Treasury Shares rose 200.0% year-over-year to $68000.0 in Q4 2023; TTM through Dec 2023 was $68000.0, a 200.0% increase from a year earlier, with the FY2023 full-year figure at $68000.0, up 200.0% from the prior year.
- Treasury Shares was $68000.0 for Q4 2023 at Apollomics, up from -$68000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.6 million in Q4 2021 and troughed at -$68000.0 in Q4 2022.
- A 3-year average of $428750.0 and a median of $68000.0 in 2022 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares tumbled 104.13% in 2022 and soared 200.0% in 2023, its largest moves.
- Over 3 years, Treasury Shares stood at $1.6 million in 2021, then sank by 104.13% to -$68000.0 in 2022, then soared by 200.0% to $68000.0 in 2023.
- The last three Treasury Shares figures came in at $68000.0 (Q4 2023), -$68000.0 (Q4 2022), and $68000.0 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2022 | -68,000.00 |
| Dec 31, 2022 | -68,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 1.65 Mn |